Keymed Biosciences Statistics
Total Valuation
HKG:2162 has a market cap or net worth of HKD 13.23 billion. The enterprise value is 11.74 billion.
Market Cap | 13.23B |
Enterprise Value | 11.74B |
Important Dates
The last earnings date was Friday, March 28, 2025.
Earnings Date | Mar 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HKG:2162 has 275.60 million shares outstanding. The number of shares has increased by 0.22% in one year.
Current Share Class | n/a |
Shares Outstanding | 275.60M |
Shares Change (YoY) | +0.22% |
Shares Change (QoQ) | +0.30% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 25.19% |
Float | 184.35M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 27.60 |
PB Ratio | 4.78 |
P/TBV Ratio | 5.04 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -21.41 |
EV / Sales | 25.76 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.30.
Current Ratio | 3.30 |
Quick Ratio | 2.97 |
Debt / Equity | 0.30 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -33.92 |
Financial Efficiency
Return on equity (ROE) is -18.85% and return on invested capital (ROIC) is -11.69%.
Return on Equity (ROE) | -18.85% |
Return on Assets (ROA) | -10.23% |
Return on Invested Capital (ROIC) | -11.69% |
Return on Capital Employed (ROCE) | -20.74% |
Revenue Per Employee | 362,160 |
Profits Per Employee | -435,855 |
Employee Count | 1,258 |
Asset Turnover | 0.11 |
Inventory Turnover | 0.14 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.62% in the last 52 weeks. The beta is 0.00, so HKG:2162's price volatility has been lower than the market average.
Beta (5Y) | 0.00 |
52-Week Price Change | +52.62% |
50-Day Moving Average | 36.00 |
200-Day Moving Average | 36.06 |
Relative Strength Index (RSI) | 78.84 |
Average Volume (20 Days) | 2,534,124 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2162 had revenue of HKD 455.60 million and -548.31 million in losses. Loss per share was -2.09.
Revenue | 455.60M |
Gross Profit | 442.61M |
Operating Income | -666.26M |
Pretax Income | -541.29M |
Net Income | -548.31M |
EBITDA | -611.32M |
EBIT | -666.26M |
Loss Per Share | -2.09 |
Balance Sheet
The company has 2.29 billion in cash and 801.58 million in debt, giving a net cash position of 1.49 billion or 5.41 per share.
Cash & Cash Equivalents | 2.29B |
Total Debt | 801.58M |
Net Cash | 1.49B |
Net Cash Per Share | 5.41 |
Equity (Book Value) | 2.63B |
Book Value Per Share | 10.04 |
Working Capital | 1.83B |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 97.15%, with operating and profit margins of -146.24% and -120.35%.
Gross Margin | 97.15% |
Operating Margin | -146.24% |
Pretax Margin | -118.81% |
Profit Margin | -120.35% |
EBITDA Margin | -134.18% |
EBIT Margin | -146.24% |
FCF Margin | n/a |
Dividends & Yields
HKG:2162 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.22% |
Shareholder Yield | -0.22% |
Earnings Yield | -4.14% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |